Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,998,350 papers from all fields of science
Search
Sign In
Create Free Account
sobuzoxane
Known as:
1,2-Bis(4-isobutoxycarbonyloxymethyl-3,5-dioxo-piperazin-1-yl)ethane
, 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5-dioxopiperazin-1-yl)ethane
The orally available active prodrug of ICRF-154, a bisdioxopiperazine derivative, with cardioprotective and antineoplastic activities. Like other…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Antineoplastic Agents
Piperazines
Topoisomerase II Inhibitors
Narrower (1)
MST 16
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma
Shojiro Haji
,
J. Kiyasu
,
+10 authors
Y. Abe
Bone Marrow Transplantation
2016
Corpus ID: 22116448
Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow…
Expand
Review
2012
Review
2012
Sobuzoxane-Containing Regimens Show Promising Response As Salvage Therapy for Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and Peripheral T-Cell Lymphoma, Not Otherwise Specified…
I. Shimizu
,
Wataru Takeda
,
+8 authors
Hikaru Kobayashi
2012
Corpus ID: 79304645
Abstract 4849 Background: Peripheral T-cell lymphoma (PTCL) is an intractable entity with limited response to CHOP-like regimens…
Expand
2007
2007
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
S. Tsunoda
,
Hiroyuki Kobayashi
,
+13 authors
Y. Kano
Gan to kagaku ryoho. Cancer & chemotherapy
2007
Corpus ID: 1975924
We conducted a clinical study of MTX-HOPE (day 1, methotrexate 20 mg per os (po); day 2, hydrocortisone 100 mg intravenous (iv…
Expand
2006
2006
Crusted scabies in an adult T‐cell leukemia/lymphoma patient successfully treated with oral ivermectin
K. Yonekura
,
T. Kanekura
,
T. Kanzaki
,
A. Utsunomiya
Journal of dermatology (Print)
2006
Corpus ID: 37411767
We report an adult T‐cell leukemia/lymphoma (ATL) patient whose crusted scabies was successfully treated with oral ivermectin…
Expand
Review
2001
Review
2001
[CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
S. Honda
,
Y. Ito
,
+6 authors
K. Ohyashiki
[Rinsho ketsueki] The Japanese journal of…
2001
Corpus ID: 27449830
A 65-year-old man was admitted with swelling of the right neck and bilateral inguinal lymph nodes. Endoscopic examination…
Expand
1995
1995
Chapter 31. To Market, To Market – 1994
Xue-min Cheng
1995
Corpus ID: 53903175
Review
1993
Review
1993
[Topoisomerase inhibitors developing in Japan].
H. Furue
Gan to kagaku ryoho. Cancer & chemotherapy
1993
Corpus ID: 24454242
Irinotecan hydrochloride (CPT-11), topotecan, sobuzoxane, NC-190, and IST-622 are unique topoisomerase inhibitors and are…
Expand
Review
1993
Review
1993
[DNA topoisomerase inhibitor].
M. Hino
,
H. Niitani
Nihon rinsho. Japanese journal of clinical…
1993
Corpus ID: 32718421
DNA topoisomerases are enzymes involved in various aspects of genetic processes by catalyzing a topological change of DNA…
Expand
1991
1991
[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
K. Yamada
,
R. Ohno
,
+7 authors
Y. Mitomo
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 20659879
Late phase II trial of MST-16 for malignant lymphoma was conducted by the multi-institutions collaboration. Out of 34 patients…
Expand
1991
1991
[Early phase II study of MST-16 (sobuzoxane) on malignant lymphoma].
N. Tominaga
,
H. Teshima
,
+7 authors
T. Arima
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 44851140
Early phase II study of MST-16[4,4-(1,2-ethanediyl) bis (1-isobutoxycarbonyloxy-methyl-2, 6-piperazinedione], a derivative of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE